These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19858122)

  • 21. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Ann Rheum Dis; 2005 Oct; 64(10):1421-6. PubMed ID: 15829572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
    Odegård S; Kvien TK; Uhlig T
    J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
    Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
    Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent onset arthritis in the elderly: a 5 year longitudinal observational study.
    Glennås A; Kvien TK; Andrup O; Karstensen B; Munthe E
    J Rheumatol; 2000 Jan; 27(1):101-8. PubMed ID: 10648025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.
    Raterman HG; van Halm VP; Voskuyl AE; Simsek S; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2008 Feb; 67(2):229-32. PubMed ID: 17557891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of death in patients with celiac disease in a population-based Swedish cohort.
    Peters U; Askling J; Gridley G; Ekbom A; Linet M
    Arch Intern Med; 2003 Jul; 163(13):1566-72. PubMed ID: 12860579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
    van den Borne BE; Landewé RB; Houkes I; Schild F; van der Heyden PC; Hazes JM; Vandenbroucke JP; Zwinderman AH; Goei The HS; Breedveld FC; Bernelot Moens HJ; Kluin PM; Dijkmans BA
    Arthritis Rheum; 1998 Nov; 41(11):1930-7. PubMed ID: 9811046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study.
    Lassere MN; Rappo J; Portek IJ; Sturgess A; Edmonds JP
    Intern Med J; 2013 Jan; 43(1):66-72. PubMed ID: 22289054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.
    Young A; Koduri G; Batley M; Kulinskaya E; Gough A; Norton S; Dixey J;
    Rheumatology (Oxford); 2007 Feb; 46(2):350-7. PubMed ID: 16908509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.
    Radovits BJ; Fransen J; Al Shamma S; Eijsbouts AM; van Riel PL; Laan RF
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):362-70. PubMed ID: 20391482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
    Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study.
    Thomas E; Symmons DP; Brewster DH; Black RJ; Macfarlane GJ
    J Rheumatol; 2003 May; 30(5):958-65. PubMed ID: 12734889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.